This inventor holds 1 USPTO granted patent. Top assignee: Chiron Behring Gmbh & Co.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Susanne Modrow: Innovator in HIV Research
Introduction
Susanne Modrow is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of HIV research through her innovative work on peptides related to the virus. Her dedication to scientific advancement has led to the development of a patent that holds promise for future therapeutic applications.
Latest Patents
Susanne Modrow holds a patent for selected peptides of the group-specific antigen (gag) of HIV. This invention focuses on the preparation of specific peptides derived from the HIV gag protein, particularly the peptide sequence NPGLLETSEGCRQ. These peptides have been shown to inhibit HIV, showcasing their potential in combating the virus.
Career Highlights
Throughout her career, Susanne has been associated with Chiron Behring GmbH & Co., where she has collaborated with other experts in the field. Her work has not only advanced scientific understanding but also contributed to the development of potential treatments for HIV.
Collaborations
Some of her notable coworkers include Matthias Niedrig and Hans Joachim Wolf. Their collective efforts have fostered a collaborative environment that enhances research outcomes and drives innovation in HIV-related studies.
Conclusion
Susanne Modrow's contributions to HIV research through her patented innovations highlight her role as a key figure in the scientific community. Her work continues to inspire advancements in the fight against HIV, demonstrating the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile